KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

"AHA 2024: Muvalaplin shows promising Phase II results for elevated serum lipoprotein (a)" was originally created and ...

Both the nasal and IV forms of bumetanide had a variability in absorption of 27%, suggesting a more stable route of dosing ...

Two studies presented at AHA show the capacity of AI to improve sonographer accuracy, consistency, and workflow.

Though the results aren’t definitive, it’s not premature to suggest high-risk individuals take shelter on very hot days.

A study was conducted to determine the effect of poor childhood oral health on risk for MI, ischemic stroke, and ischemic heart disease in adulthood.

Polygenic risk scores (PRSs) are a cutting-edge tool in genetics, combining information from genetic markers across the genome to estimate a person's risk of developing certain diseases, such as ...

The American Heart Association held its annual Scientific Sessions Nov. 16-18 in Chicago, where healthcare organizations and industry leaders presented the latest research on cardiovascular health.

Middle-aged adults with long-term fluctuations in blood pressure may face a higher risk for sudden cardiac death than their ...

Adena Regional Medical Center (ARMC) recently received several honors for those two service lines through the American Heart Association’s Get With the Guidelines® awards program for its quality care, ...

Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention ...

(TSX: CRDL) has seen success under a phase II trial conducted on CardiolRx, which is the company’s lead small molecule drug ...